Literature DB >> 10381114

Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997.

A Hakanen1, A Siitonen, P Kotilainen, P Huovinen.   

Abstract

Antimicrobial resistance trends were examined for 811 salmonella isolates from humans collected in Finland during 1995-1997. The material was divided into domestic and foreign isolates according to the origin of infection. A total of 2.3% of the 387 domestic and 7.8% of the 424 foreign isolates were quinolone-resistant (P < 0.001). Among the domestic isolates we detected an emergence of ciprofloxacin resistance (MIC > or = 0.25 mg/L) with the proportion of resistant isolates increasing from 0 to 2.2% (P = 0.2). Among the foreign isolates this increase was even more dramatic, from 2.0% to 8.4% (P = 0.037) during the study period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381114     DOI: 10.1093/jac/43.1.145

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  Genotypic analysis of Escherichia coli strains from poultry carcasses and their susceptibilities to antimicrobial agents.

Authors:  I Geornaras; J W Hastings; A von Holy
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Authors:  Antti J Hakanen; Marianne Lindgren; Pentti Huovinen; Jari Jalava; Anja Siitonen; Pirkko Kotilainen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 3.  Fluoroquinolones in paediatrics.

Authors:  D Gendrel; F Moulin
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora.

Authors:  M Osterblad; A Hakanen; R Manninen; T Leistevuo; R Peltonen; O Meurman; P Huovinen; P Kotilainen
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.

Authors:  A Hakanen; P Kotilainen; J Jalava; A Siitonen; P Huovinen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.

Authors:  José M Marimón; María Gomáriz; Carmen Zigorraga; Gustavo Cilla; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Antimicrobial resistance among Salmonella and Shigella isolates in five Canadian provinces (1997 to 2000).

Authors:  Leah J Martin; James Flint; André Ravel; Lucie Dutil; Kathryn Doré; Marie Louie; Frances Jamieson; Sam Ratnam
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-07       Impact factor: 2.471

8.  Impact of feed supplementation with antimicrobial agents on growth performance of broiler chickens, Clostridium perfringens and enterococcus counts, and antibiotic resistance phenotypes and distribution of antimicrobial resistance determinants in Escherichia coli isolates.

Authors:  Moussa S Diarra; Fred G Silversides; Fatoumata Diarrassouba; Jane Pritchard; Luke Masson; Roland Brousseau; Claudie Bonnet; Pascal Delaquis; Susan Bach; Brent J Skura; Edward Topp
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

9.  Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.

Authors:  A Hakanen; P Kotilainen; P Huovinen; H Helenius; A Siitonen
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC.

Authors:  Hideo Nakaya; Akihiro Yasuhara; Ken Yoshimura; Yukio Oshihoi; Hidemasa Izumiya; Haruo Watanabe
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.